Clovis Oncology Submits NDA for Rociletinib for the Treatment of Advanced EGFR-Mutant T790M+ Non-small Cell Lung Cancer

… with T790M-positive EGFR-mutant non-small cell lung cancer. We are also actively building … treatment of EGFR-mutated non-small cell lung cancer (NSCLC). Rociletinib targets the activating … and MEK. About Lung Cancer and EGFR Mutations Lung cancer is the most common …